In an exciting collaboration set to debut at the 2024 SEMA Show in Las Vegas, RealTruck Inc. has partnered with renowned automotive designer Chip Foose to create a one-of-a-kind truck. The custom 2021 Ford F-150, designed by Foose, will be unveiled at RealTruck’s booth on November 5, 2024, at 11:30 a.m. PST, through a live stream press conference.
Chip Foose, best known for his iconic designs featured on the television show Overhaulin’, has brought his signature vision to this collaboration, blending innovative design elements with RealTruck’s premium aftermarket parts. The customized truck will be equipped with an impressive array of RealTruck accessories, including a RealTruck Traction Recovery Winch, Rugged Ridge Traction Recovery Kit, and Go Rhino bumpers, among others.
But this partnership goes beyond the world of automotive design. The truck will be auctioned off at Barrett-Jackson’s Scottsdale, Arizona event in January 2025, with all proceeds benefiting The Progeria Research Foundation. Progeria is a rare genetic disorder that causes rapid aging in children, and the charity is close to Foose’s heart due to his sister’s passing from the disease at the age of 16.
“It’s been an exciting time working with Chip on this unique build,” said Lee Riser, Vice President of Marketing at RealTruck. “This collaboration is a chance to bring Chip’s vision to life while supporting a cause that matters deeply to him.”
Foose himself expressed his gratitude for RealTruck’s involvement in this project, saying, “All proceeds from this customized truck will go to The Progeria Research Foundation, a charity that is near and dear to my heart. We’re excited to unveil it at SEMA this year.”
Following its debut, the truck will become part of the charity auction at Barrett-Jackson, where 100% of the sale price will benefit the foundation. This initiative is expected to raise both awareness and critical funds for advancing research into the cure for Progeria.
The Progeria Research Foundation, founded in 1999, has been instrumental in securing groundbreaking research funding and supporting the clinical trials that led to the FDA approval of the first-ever Progeria treatment, lonafarnib (Zokinvy®). The foundation’s mission is to find a cure for Progeria, and their work is not only advancing treatments for this rare disease but also holds promise for breakthroughs in aging-related diseases, including heart disease and stroke…